Human herpes virus 8 (HHV-8) in Kaposi's sarcoma: Lack of association with Bcl-2 and p53 protein expression

Journal of Clinical Pathology - Molecular Pathology

Volumn 51, Issue 3, 1998, Pages 155-159

  Kennedy, M M ^a   O'Leary, J J ^a   Oates, J L ^b   Lucas, S B ^c   Howells, D D ^d   Picton, S ^d   McGee, J O'D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d PE Applied Biosystems   (United Kingdom)

Author keywords

Bcl 2; Human herpes virus 8; Immunohistochemistry; p53; TaqMan PCR

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; FEMALE; HERPES VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; MALE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS REPLICATION;

EID: 0031878426     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.51.3.155     Document Type: Article

References (43)

1. Schulz TF, Weiss RA. Kaposi's sarcoma: a linger on the culprit. Nature 1995;373:17-18.
2. Chang Y, Cesarman K, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-assoeiated Kaposi's sarcoma. Science 1994;266:1865-9.
3. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995;268:582-3.
4. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995;345:1043-4.
5. Dupin N, Grandadam M, Calvez V, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995'345:761-2.
6. Chang Y, Ziegler J, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Arch Intern Med 1996;156:202-4.
7. Gao S-J, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpes virus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996;335:233-41.
8. Gao S-J, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996;2:925-8.
9. Kedes DH, Operskalski E, Busch M, et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2:918-24.
10. Lennette ET, Blackbourn DJ, Lew JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-61.
11. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluoresence antigen. Lancet 1996;348:1133-8.
12. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
13. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80.
14. Rettig MB, Ma HJ, Vescio RA, et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997;276: 1851-4.
15. Moore PS, Gao S-J, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1996;70:549-58.
16. Neipel F, Albrecht J-C, Fleckenstein B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J Virol 1997;71:4187-92.
17. Ensoli B, Nakamura S, Salahuddin SZ, et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989;243:223-6.
18. Stürzl M, Roth WK, Brockmeyer NH, et al. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci USA 1992;89:7046-50.
19. Miles SA, Rezai AR, Salazar-Gonzalez JF, et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 1990;87:4068-72.
20. Bohan-Morris C, Gendelman R, Marrogi AJ, et al. Immunohistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma. Am J Pathol 1996;148:1055-63.
21. L. Am J Pathol 1996;149:795-803.
22. Dada MA, Chetty R, Biddolph SC, et al. The immunoexpression of bcl-2 and p53 in Kaposi's sarcoma. Histopathology 1996;29:159-63.
23. Kennedy MM, Lucas SB, Jones RR, et al. HHV8 and Kaposi's sarcoma: a time cohort study. J Clin Pathol: Mol Pathol 1997;50:96-100.
24. Sarid R, Sato T, Bohenzky RA, et al. Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue. Nat Med 1997;3:293-8.
25. Cheng EHY, Nicholas J, Bellows DS, et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA 1997;94:690-4.
26. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the Bcl 2 family and cell death. Blood 1996;88:386-401.
27. Kernohan NM, Cox LS. Regulation of apoptosis by Bcl-2 and its related proteins: immunochemical challenges and therapeutic implications. J Pathol 1996;179:1-3.
28. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts and protein products of Bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986;83:5214-18.
29. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:119-28.
30. Lane DP. A death in the life of p53. Nature 1993;362:786-7.
31. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 1995; 80:293-9.
32. Teodoro JG, Branton PE. Regulation of apoptosis by viral gene products. J Virol 1997;71:1739-46.
33. Rao L, Debbas M, Sabbatini P, et al. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 1992; 89:7742-6.
34. Henderson S, Huen D, Rowe M, et al. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci 1993;90:8479-83.
35. Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991;65:1107-15.
36. Mori S, Murakami-Mori K, Jewett A, et al. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis. Cancer Res 1996;56:1874-9.
37. Zhong W, Wang H, Herndier B, et al. Restricted expression of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 1996;93:6641-6.
38. Pezzella F, Gatter K. What is the value of Bcl-2 protein detection for histopathologists? Histopathology 1995;26:89-93.
39. Li JJ, Huang YQ, Cockerell CJ, et al. Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma. Am J Dermatopathol 1997;19:373-8.
40. Bergman R, Ramon M, Kilim S, et al. An immunohistochemical study of p53 protein expression in classical Kaposi's sarcoma. Am J Dermatopathol 1996;18:367-70.
41. CIP1 WAI-1 Sdi1. J Pathol 1997;183:134-40.
42. Moore PS, Boshoff C, Weiss RA, et al. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274:1739-14.
43. Chang Y, Moore PS, Talbot SJ, et al. Cyclin encoded by KS herpesvirus. Nature 1996;382:410.